logo
Chinese hospital offers IVF for single women, allows them to meet, evaluate sperm donors

Chinese hospital offers IVF for single women, allows them to meet, evaluate sperm donors

A private hospital in eastern China is under investigation for offering illegal in vitro fertilisation (IVF) services specifically for single women, allowing them to meet and choose sperm donors.
The Nantai Integrated Chinese and Western Medicine Hospital, located in Nanjing, Jiangsu province, was shut down and is being probed by the local health commission after a media outlet uncovered its illicit IVF operations.
Not listed among the official hospitals authorised to provide these services, the facility advertised that it could help single women conceive for a minimum fee of about 100,000 yuan (US$14,000).
An unidentified doctor from the hospital informed Shandian News that the sperm is sourced directly from donors, who are primarily young men around 25 years old.
The doctor explained that clients could select a donor based on various criteria, including appearance, educational background, nationality, and even the option to meet the donor in person.
The hospital permitted clients to choose a donor based on various criteria, including physical appearance, educational background, nationality, and even the opportunity to meet the donor in person. Photo: Shutterstock
'You can choose graduates from prestigious universities involved in the '985' and '211' initiatives, or men holding a master's or PhD degree. The cost increases with the level of education,' the doctor noted.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

EU set to clamp down on China's access to medical device market as trade tensions simmer
EU set to clamp down on China's access to medical device market as trade tensions simmer

South China Morning Post

timean hour ago

  • South China Morning Post

EU set to clamp down on China's access to medical device market as trade tensions simmer

European Union member states are expected to vote on Monday to restrict access to the bloc's vast procurement markets for Chinese medical device manufacturers in response to Beijing's refusal to open its own tenders to EU firms. It would mark the first use of the bloc's international procurement instrument (IPI) and comes after fruitless negotiations on market access with the Chinese government. Diplomatic sources said the vote was expected to pass, meaning the curbs could be implemented within weeks. The vote could add another layer of tension before the sides' trade chiefs meet on Tuesday. Maros Sefcovic and Wang Wentao were expected to see each other on the margins of an Organisation for Economic Cooperation and Development (OECD) ministerial conference in Paris, with a meeting slated for 4.30pm, EU sources said. 01:44 China's largest EV battery maker CATL celebrates strong debut at Hong Kong stock market China's largest EV battery maker CATL celebrates strong debut at Hong Kong stock market Sources said they were expected to attend a dinner gathering of 'influential' trade ministers organised by the World Trade Organization director general Ngozi Okonjo-Iweala. In January, a European Commission investigation concluded that there was 'clear evidence of China limiting access by EU medical device producers to its government contracts in an unfair and discriminatory way'. According to Brussels, Chinese medical device manufacturers have largely free access to public procurement tenders in the EU market, compared to the restrictions faced by European competitors in China. The EU probe singled out Beijing's 'Buy China' policies – particularly in the high-end segment of the medical device sector – as designed 'to directly favour domestic medical devices to the detriment of imported ones'. It noted that the devices were among the 10 designated under the Made in China 2025 programme, with targets for domestically produced products to account for half of all those used in county hospitals by 2020, 70 per cent by 2025 and 90 per cent by 2030.

Hong Kong public hospitals to step up testing for rare rotavirus: disease expert
Hong Kong public hospitals to step up testing for rare rotavirus: disease expert

South China Morning Post

time3 hours ago

  • South China Morning Post

Hong Kong public hospitals to step up testing for rare rotavirus: disease expert

Hong Kong public hospitals will step up surveillance of a rare virus and test patients with severe diarrhoea, infectious diseases expert Yuen Kwok-yung has said, after it was found in a doctor who died shortly after feeling unwell. The University of Hong Kong's chair of infectious diseases on Monday revealed the latest move following the release of findings on the death of a doctor initially thought to be linked with a group of oncologists suspected of being infected with a toxic strain of E coli. The Centre for Health Protection confirmed last Friday that there had in fact been no E coli outbreak in the oncology department of Princess Margaret Hospital in Kwai Chung, where the three doctors worked. But group C rotavirus, which was known but rare, was found in various tissue samples of the doctor who died just three days after he developed diarrhoea in February 'We need to continue to monitor whether a similar situation will happen,' Yuen, who led a team of experts assisting the investigation, told a radio programme. 'In the future, the Hospital Authority will test for this virus on patients with severe diarrhoea, especially those requiring treatment at intensive care units. If other diarrhoea-causing viruses cannot be found, we will test for group C rotavirus.'

A soothing cup of rice? Chinese scientists create grain with health benefits of tea
A soothing cup of rice? Chinese scientists create grain with health benefits of tea

South China Morning Post

time5 hours ago

  • South China Morning Post

A soothing cup of rice? Chinese scientists create grain with health benefits of tea

Chinese scientists have engineered the first 'tea rice' enriched with the antioxidant compounds that make green tea a health-boosting drink. Advertisement The rice has been fortified with the micronutrient catechin, and the researchers behind it say it can provide the health benefits of tea without any side effects from caffeine. 'Catechins, as key antioxidant components in tea plants with high content, offer certain benefits to human health,' the team said in a paper published in the peer-reviewed Plant Biotechnology Journal in March. 01:33 2-metre 'giant rice' twice as tall as other varieties nearly ready for first harvest in China 2-metre 'giant rice' twice as tall as other varieties nearly ready for first harvest in China Catechin flavonoids are a type of polyphenol – micronutrients that occur naturally in plants – shown to have antibacterial, anti-inflammatory, anticancer and cardioprotective properties. Catechins are thought to play a role in regulating blood pressure, aiding in weight loss, and lowering the risk of cardiovascular disease. 'These essential flavonoid phytonutrients are renowned for their pivotal role in bestowing the unique health benefits associated with tea plant consumption,' the team said. Advertisement Catechins make up around 15 to 30 per cent of the dry weight of tea, with particularly high levels found in green tea as it does not undergo the same oxidation process that black tea does during processing. While green tea contains these beneficial compounds, it also contains caffeine, which can cause people to experience symptoms like insomnia and heart palpitations, particularly when consumed in large amounts.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store